ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Growth-hungry Gilead acquires Kite at $12B for its nearly approved CAR-T treatment
August 29, 2017Gilead Sciences will buy Kite Pharma for nearly $12 billion, when Kite's cutting-edge CAR-T treatment is nearly approved. -
Deals of Biotech down by half possibly making it the lowest since 2013
August 21, 2017Valuations are too high in biotech, that's what Big Pharma CEOs have stated in their last few quarterly financials again and again. -
China's Fosun, Shanghai Pharma circle Georgia drugmaker Arbor for U.S. beef-up
August 15, 2017Fosun and Shanghai Pharma are bidding for a stake in U.S. drugmaker Arbor Pharma, as the Chinese banking authorities crack down on debt-fueled foreign acquisitions. -
Trends in pharmaceutical mergers and acquisitions
February 20, 2017The number of mergers and acquisitions in the pharmaceutical industry has continued to rise, with oncology being a particularly active area and assets increasingly being acquired at earlier stages of their development.
Pharma Sources Insight January 2025
